AU1521199A - Crystal comprising human immunodeficiency virus envelope glycoprotein gp120, compounds inhibiting cd4-gp120 interaction, compounds inhibiting chemokine receptor-gp120 interaction, mimics of cd4 and gp120 variants - Google Patents
Crystal comprising human immunodeficiency virus envelope glycoprotein gp120, compounds inhibiting cd4-gp120 interaction, compounds inhibiting chemokine receptor-gp120 interaction, mimics of cd4 and gp120 variantsInfo
- Publication number
- AU1521199A AU1521199A AU15211/99A AU1521199A AU1521199A AU 1521199 A AU1521199 A AU 1521199A AU 15211/99 A AU15211/99 A AU 15211/99A AU 1521199 A AU1521199 A AU 1521199A AU 1521199 A AU1521199 A AU 1521199A
- Authority
- AU
- Australia
- Prior art keywords
- interaction
- compounds inhibiting
- mimics
- variants
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 230000002401 inhibitory effect Effects 0.000 title 2
- 230000003993 interaction Effects 0.000 title 2
- 102000019034 Chemokines Human genes 0.000 title 1
- 108010012236 Chemokines Proteins 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 102100021696 Syncytin-1 Human genes 0.000 title 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96698797A | 1997-11-10 | 1997-11-10 | |
| US96693297A | 1997-11-10 | 1997-11-10 | |
| US96740397A | 1997-11-10 | 1997-11-10 | |
| US96714897A | 1997-11-10 | 1997-11-10 | |
| US08966932 | 1997-11-10 | ||
| US08967148 | 1997-11-10 | ||
| US08966987 | 1997-11-10 | ||
| US08967403 | 1997-11-10 | ||
| US97674197A | 1997-11-24 | 1997-11-24 | |
| US08976741 | 1997-11-24 | ||
| US10076398A | 1998-06-18 | 1998-06-18 | |
| US10052198A | 1998-06-18 | 1998-06-18 | |
| US10063198A | 1998-06-18 | 1998-06-18 | |
| US10076298A | 1998-06-18 | 1998-06-18 | |
| US10052998A | 1998-06-18 | 1998-06-18 | |
| US09100529 | 1998-06-18 | ||
| US09100762 | 1998-06-18 | ||
| US09100631 | 1998-06-18 | ||
| US09100763 | 1998-06-18 | ||
| US09100521 | 1998-06-18 | ||
| PCT/US1998/023905 WO1999024553A2 (en) | 1997-11-10 | 1998-11-10 | X-ray crystal comprising hiv-1 gp120 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1521199A true AU1521199A (en) | 1999-05-31 |
Family
ID=27580988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU15211/99A Abandoned AU1521199A (en) | 1997-11-10 | 1998-11-10 | Crystal comprising human immunodeficiency virus envelope glycoprotein gp120, compounds inhibiting cd4-gp120 interaction, compounds inhibiting chemokine receptor-gp120 interaction, mimics of cd4 and gp120 variants |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU1521199A (en) |
-
1998
- 1998-11-10 AU AU15211/99A patent/AU1521199A/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0831873A4 (en) | The treatment of hiv and other viral infections using combinatory therapy | |
| AU5726694A (en) | Human immunodeficiency virus decoy | |
| EP0635262A3 (en) | Package structure of drug-containing pressure-sensitive adhesive sheet. | |
| CA2309818A1 (en) | Buffered drug formulations for transdermal electrotransport delivery | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| AU1539699A (en) | Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy | |
| AU4985496A (en) | Administration of a cyclosporine-specific monoclonal antibody that cross-reacts with hiv-1 p24 gag to treat hiv infection | |
| AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
| AU3854797A (en) | Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection | |
| AU4954596A (en) | Recombinant human immunodeficiency virus-producing cell | |
| NZ307494A (en) | Lymphokine capable of inhibiting immunodeficiency viruses | |
| AU1192892A (en) | Pharmaceutical preparation of antistress, stress-preventive and nootropic action | |
| AU5848794A (en) | Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use | |
| AU1521199A (en) | Crystal comprising human immunodeficiency virus envelope glycoprotein gp120, compounds inhibiting cd4-gp120 interaction, compounds inhibiting chemokine receptor-gp120 interaction, mimics of cd4 and gp120 variants | |
| EP0323157A3 (en) | Antiviral compounds and methods | |
| WO1996001110A3 (en) | Anti-hiv triple combination | |
| AU6853298A (en) | Transgenic mouse expressing human cd4 and fusin (cxcr4) | |
| CA2317107A1 (en) | Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus | |
| AU2023092A (en) | New hiv-1 gag and env peptides, diagnostic | |
| EP1037963A4 (en) | X-ray crystal comprising hiv-1 gp120 | |
| CA2232222A1 (en) | Treatment of hiv positive patients | |
| AU5761900A (en) | Human monoclonal antibodies to hiv-1 envelope glycoprotein gp120 | |
| AU5776896A (en) | Means for detecting and preventing HIV infection involving use of receptors or binding sites capable of interacting with GP120 | |
| AU1189899A (en) | Inhibition of human immunodeficiency virus (hiv-1) replication | |
| AU1032701A (en) | Deglycosylated env/cd4 complex and the use thereof for vaccination against hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |